Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOX in Platinum-resistant Nasopharyngeal Carcinoma
NCT01403259Phase 2Terminated
- Sponsor
- Fudan University
- Start
- Jul 2011
- Primary completion
- Dec 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur, oxaliplatin in nasopharyngeal carcinoma (NPC), sponsored by Fudan University. Started Jul 2011; status: terminated.
02
Drugs
tegafuroxaliplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT01403259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01403259.